Acquisition of Aquarius Biotechnologies, Inc. (now Matinas Biopharma Nanotechnologies, Inc.) - Schedule of Fair Value of Contingent Transferred in Acquisition (Details) (Parenthetical) - Aquarius Biotechnologies, Inc. [Member]
Jan. 29, 2015
$ / shares
|Business acquisition, equity interest issued or issuable, number of shares | shares||4,608,020|
|Price per share | $ / shares||$ 0.46|
Number of shares of equity interests issued or issuable to acquire entity.
Reference 1: http://www.xbrl.org/2003/role/presentationRef